Effect of estrogen receptor (ER) on benzo [a]pyrene-DNA adduct formation in human breast cancer cells

Journal of Toxicology and Environmental Health - Part A

Volumn 68, Issue 21, 2005, Pages 1833-1840

  Kang, Se Chan ^a   Lee, Byung Mu ^a  

^a Sungkyunkwan University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

BENZO[A]PYRENE; ESTRADIOL; ESTROGEN; ESTROGEN RECEPTOR; TAMOXIFEN;

ARTICLE; BREAST CANCER; CANCER CELL; CANCER CELL CULTURE; CARCINOGENESIS; CELL STRAIN MCF 7; CELL TRANSFORMATION; DNA ADDUCT; DNA BINDING; DNA SYNTHESIS; DNA SYNTHESIS INHIBITION; DRUG EFFECT; DRUG MECHANISM; ESTROGEN ACTIVITY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; BIOSYNTHESIS; BREAST TUMOR; CELL CULTURE; FEMALE; METABOLISM; PATHOLOGY; PHYSIOLOGY;

MINK CELL FOCUS-FORMING VIRUS;

BENZO(A)PYRENE; BREAST NEOPLASMS; CELL TRANSFORMATION, NEOPLASTIC; DNA ADDUCTS; FEMALE; HUMANS; RECEPTORS, ESTROGEN; TUMOR CELLS, CULTURED;

EID: 27244438275     PISSN: 15287394     EISSN: 10872620     Source Type: Journal    
DOI: 10.1080/15287390500182883     Document Type: Article

References (28)

1. Angus, W. G., Larsen, M. C., and Jefcoate, C. R. 1999. Expression of CYP1A1 and CYP1B1 depends on cell-specific factors in human breast cancer cell lines: Role of estrogen receptor status. Carcinogenesis 20:947-955.
2. Aranda, A., and Pascual, A 2001. Nuclear hormone receptors and gene expression. Physiol. Rev. 81:1269-1304.
3. Berge, G., Mollerup, S., Ovrebo, S., Hewer, A., Phillips, D. H., Eilertsen, E., and Haugen, A. 2004. Role of estrogen receptor in regulation of polycyclic aromatic hydrocarbon metabolic activation in lung. Lung Cancer 45:289-297.
4. Boffetta, P., Jourenkova, N., and Gustavsson, P. 1997. Cancer risk from occupational and environmental exposure to polycyclic aromatic hydrocarbons. Cancer Causes Control 8:444-472.
5. Cavalieri, E., and Rogan, E. 1990. Role of radical cations in aromatic hydrocarbon carcinogenesis. Environ. Health Perspect. 64:69-84.
6. Choi, S. M., Yoo, S. D., and Lee, B. M. 2004. Toxicological characteristics of endocrine-disrupting chemicals: Developmental toxicity, carcinogenicity, and mutagenicity. J. Toxicol. Environ. Health B. 7:1-24.
7. Colborn, T., vom Saal, F. S., and Soto, A. M. 1993. Developmental effects of endocrine-disrupting chemicals in wildlife and humans. Environ. Health Perspect. 101:378-384.
8. DeRosa, C., Richter, P., Pohl, H., and Jones, D. E. 1998. Environmental exposures that affect the endocrine system: Public health implications. J. Toxicol. Environ. Health B: Critical Reviews. 1:3-26.
9. Dohr, O., Vogel, C., and Abel, J. 1995. Different response of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD)-sensitive genes in human breast cancer MCF-7 and MDA-MB 231 cells. Arch. Biochem. Biophys. 321:405-412.
10. Donovan, P. J., Smith, G. T., and Nardone, R. 2004. The mutagenic effects of 7,12-dimethylbenz[a]anthacene, 3-methylcholanthrene and benzo[a]pyrene to the developing Syrian hamster fetus measured by an in vivo/in vitro mutation assay. Mutat. Res. 554:111-120.
11. Fu, M., Wang, C., Zhang, X., and Pestell, R. 2003. Nuclear receptor modifications and endocrine cell proliferation. J. Steroid Biochem. Mol. Biol. 85:133-138.
12. Hoivik, D., Willett, K., Wilson, C., and Safe, S. 1997. Estrogen does not inhibit 2,3,7,8-tetrachlorodibenzo-p-dioxin-mediated effects in MCF-7 and Hepa 1c1c7 cells. J. Biol. Chem. 272:30270-30274.
13. Jana, N. R., Sarkar, S., Ishizuka, M., Yonemoto, J., Tohyama, C., and Sone, H. 1999. Cross-talk between 2,3,7,8-tetrachlorodibenzo-p-dioxin and testosterone signal transduction pathways in LNCaP prostate cancer cells. Biochem. Biophys. Res. Commun. 256:462-468.
14. Kazeto, Y., Place, A. R., and Trant, J. M. 2004. Effects of endocrine disrupting chemicals on the expression of CYP19 genes in zebrafish (Danio rerio) juveniles. Aquat. Toxicol. 69:25-34.
15. Kwack, S. J., and Lee, B. M. 2000. Correlation between DNA or protein adducts and benzo[a]pyrene diol epoxide I-triglyceride adduct detected in vitro and in vivo. Carcinogenesis 21:629-632.
16. Lehner, A., Horn, J., and Flesher, J. 2004. Formation of radical cations in a model for the metabolism of aromatic hydrocarbons. Biochem. Biophys. Res. Commun. 322:1018-1023.
17. Lin, P., Chang, J. T., Ko, J. L., Liao, S. H., and Lo, W. S. 2004. Reduction of androgen receptor expression by benzo[alpha]pyrene and 7,8-dihydro-9,10-epoxy-7,8,9,10-tetrahydrobenzo[alpha]pyrene in human lung cells. Biochem. Pharmacol. 67:1523-1530.
18. Robinson-Rechavi, M., Garcia, E. G., and Laudet, V. 2003. The nuclear receptor superfamily. J. Cell Sci. 116:585-586.
19. Rogan, E. G., and Cavalieri, E. L. 2004. Estrogen metabolites, conjugates, and DNA adducts: Possible biomarkers for risk of breast, prostate, and other human cancers. Adv. Clin. Chem. 38:135-149.
20. Roy, D., Palangat, M., Chen, C. W., Thomas, R. D., Colerangle, J., Atkinson, A., and Yan, Z. J. 1997. Biochemical and molecular changes at the cellular level in response to exposure to environmental estrogen-like chemicals. J. Toxicol. Environ. Health. 50:1-29.
21. Sanchez-Margalet, V., Gonzalez-Yanes, C., and Najib, S. 2001. Pancreastatin, a chromogranin A-derived peptide, inhibits DNA and protein synthesis by producing nitric oxide in HTC rat hepatoma cells. J. Hepatol. 35:80-85.
22. Singh, S. V., Benson, P. J., Pal, A., Xia, H., Srivastava, S. K., and Awasthi, S. 1998. Gender-related differences in susceptibility of A/J mouse to benzo[a]pyrene-induced pulmonary and forestomach tumorigenesis. Cancer Lett 128:197-204.
23. Sumpter, J. P. 1998. Xenoendocrine disrupters-environmental impacts. Toxicol. Lett. 28:102-103. 337-342.
24. Thomsen, J. S., Wang, X., Hines, R. N., and Safe, S. 1994. Restoration of aryl hydrocarbon (Ah) responsiveness in MDA-MB-231 human breast cancer cells by transient expression of the estrogen receptor. Carcinogenesis 15:933-937.
25. Vinggaard, A. M., Hnida, C., and Larsen, J. 2000. Environmental polycyclic aromatic hydrocarbons affect androgen receptor activation in vitro. Toxicology 145:173-183.
26. Vyhlidal, C., Li, X., and Safe, S. 2002. Estrogen regulation of transferrin gene expression in MCF-7 human breast cancer cells. J. Mol. Endocrinol. 29:305-317.
27. Wang, W. L., Thomsen, J. S., Porter, W., Moore, M., and Safe, S. 1996. Effect of transient expression of the oestrogen receptor on constitutive and inducible CYP1A1 in Hs578T human breast cancer cells. Br. J. Cancer. 73:316-322.
28. Whitlock, J. P., Jr. 1999. Induction of cytochrome P4501A1. Annu. Rev. Pharmacol. Toxicol. 39:103-125.